TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Karo Pharma AS
Closing information (x1000 DKK)
Closing information | 2019/12 | 2018/12 | 2017/12 |
Turnover | 335,552 | 342,460 | 300,321 |
Financial expenses | 982 | 1,129 | 557 |
Earnings before taxes | 56,141 | 88,135 | 56,440 |
Total assets | 228,166 | 221,173 | 188,835 |
Current assets | 181,726 | 148,952 | 109,037 |
Current liabilities | 125,817 | 125,002 | 97,317 |
Equity capital | 100,410 | 94,024 | 88,309 |
- share capital | 5,149 | 5,061 | 5,143 |
Employees (average) | 22 | 21 | 21 |
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Solvency | 44.0% | 42.5% | 46.8% |
Turnover per employee | 15,252 | 16,308 | 14,301 |
Profit as a percentage of turnover | 16.7% | 25.7% | 18.8% |
Return on assets (ROA) | 25.0% | 40.4% | 30.2% |
Current ratio | 144.4% | 119.2% | 112.0% |
Return on equity (ROE) | 55.9% | 93.7% | 63.9% |
Change turnover | -12,812 | 46,919 | -2,110 |
Change turnover % | -4% | 16% | -1% |
Chg. No. of employees | 1 | 0 | -9 |
Chg. No. of employees % | 5% | 0% | -30% |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.